drugset / Trial / NCT00992576

Optimisation of Hydromorphone - Naloxone Ratio for the Treatment of Pain

NCT00992576

Phase 2/3 Completed 600 enrolled Mundipharma Research GmbH & Co KG
RandomizedParallel-groupDouble-blindTreatment

Summary

The purpose of this study is to establish an optimal hydromorphone - naloxone ratio with an improved bowel function for constipated pain patients.

Timeline

Start
2010-01
Primary completion
2011-11
Completion
2012-01

Drugs

EvaluationDrugModalityDoseRoute
Subject Hydromorphone Other / unclassified
Subject Naloxone Small molecule

Indications